Comparison of the Effect of NN5401 With the Effect of NN1250 and Insulin Aspart in Type 1 Diabetics
Status:
Completed
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe. The aim of this clinical trial is to compare the blood
glucose lowering effect of NN5401(insulin degludec/insulin aspart (IDegAsp)) with NN1250
(insulin degludec (IDeg)) and insulin aspart (IAsp) in subjects with type 1 diabetes where
the trial participant will receive one single dose of each trial product in varying order.